LobbyingMind Medicine lobbying by quarter
Mind Medicine's latest lobbying report covers Q3 2024, at $15K. Its first report covers Q2 2023; the issues it reports most are Health Issues and Pharmacy.
Mind Medicine
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $30K | 1 |
| Q3 2023 | $30K | 1 |
| Q4 2023 | $30K | 1 |
| Q1 2024 | $15K | 1 |
| Q2 2024 | $15K | 1 |
| Q3 2024 | $15K | 1 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$90K · 3 reports
- Pharmacy$15K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE4 reports
- HOUSE OF REPRESENTATIVES2 reports
Firms it paid
| Firm | ||
|---|---|---|
| The KPM Group DC | $135K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/10/31for Q3 2024 | The KPM Group DC | $15K |
| 24/10/31for Q2 2024 | The KPM Group DC | $15K |
| 24/10/31for Q1 2024 | The KPM Group DC | $15K |
| 24/10/21for Q3 2024 | The KPM Group DC | $30K |
| 24/10/21for Q3 2024 | The KPM Group DC | $30K |
| 24/09/17for Q3 2023 | The KPM Group DC | $30K |
| 24/07/19for Q2 2024 | The KPM Group DC | $30K |
| 24/04/19for Q1 2024 | The KPM Group DC | $30K |
| 24/01/22for Q4 2023 | The KPM Group DC | $30K |
| 23/10/20for Q3 2023 | The KPM Group DC | $30K |
| 23/07/19for Q2 2023 | The KPM Group DC | $30K |
| 23/06/30for Q2 2023 | The KPM Group DC | Under $5,000 |